Cargando…

P1583: EVALUATION OF THE KNOWLEDGE OF HEMATOLOGISTS ABOUT THE MANAGEMENT OF INFECTIOUS COMPLICATIONS IN HEMATOLOGIC PATIENTS

Detalles Bibliográficos
Autores principales:	Guaraná, M., Nucci, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431341/ http://dx.doi.org/10.1097/01.HS9.0000849188.54223.7b

Ejemplares similares

P1583: TRANSFUSIONS IN AUTOIMMUNE HEMOLYTIC ANEMIA: FREQUENCY AND CLINICAL SIGNIFICANCE OF ALLOIMMUNIZATION
por: Versino, Francesco, et al.
Publicado: (2023)

Reglage des "Gates Control" U 1583
por: Hoh, R
Publicado: (1976)

Identifying Educational Needs and Practice Gaps of European Hematologists and Hematology Nurses in the Treatment and Management of Multiple Myeloma
por: Murray, Suzanne, et al.
Publicado: (2018)

P1608: EXPERIENCE AND COMPLICATIONS WITH THE USE OF PICCS IN HEMATOLOGIC PATIENTS
por: Sanchez-Paz, L., et al.
Publicado: (2022)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
por: Küçük, Mert, et al.
Publicado: (2013)

Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists
por: Kohno, Kei, et al.
Publicado: (2014)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center
por: Hansra, D. M., et al.
Publicado: (2018)

1583P COVID-19 related risk in patients enrolled in early-phase clinical trials
por: D'Amico, P., et al.
Publicado: (2021)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
por: Kritharis, Athena, et al.
Publicado: (2018)

1583. In Vitro Activity of Imipenem/Relebactam against Klebsiella pneumoniae and Pseudomonas aeruginosa from Patients in ICUs in the Asia/Pacific region – SMART 2015-2018
por: Lob, Sibylle, et al.
Publicado: (2020)

Infections in patients with chronic lymphocytic leukemia
por: Guarana, Mariana, et al.
Publicado: (2023)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

P-084: INFECTIOUS PROFILE OF SICKLE CELL PATIENTS IN THE HEMATOLOGY DEPARTMENTS OF CONAKRY UNIVERSITY HOSPITAL
por: M., DIAKITE, et al.
Publicado: (2022)

P1626: MANAGEMENT OF POST-TRANSFUSION COMPLICATIONS IN PATIENTS WITH HEMATOLOGICAL DISEASES. PREVENTION IS BETTER THAN CURE–DATA FROM A SINGLE INSTITUTION
por: Lazarova, Y., et al.
Publicado: (2022)

PB2266: INFECTIVE ENDOCARDITIS IN NEUTROPENIC PATIENTS: A SYSTEMATIC REVIEW
por: Guaraná, M., et al.
Publicado: (2022)

P1553: RISK-ADAPTED IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH ACUTE LEUKEMIA: CLINICAL EVALUATION FOR INFECTIOUS COMPLICATIONS.
por: Gerasimovich, Olga, et al.
Publicado: (2023)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Acute Mesenteric Thrombosis: A Hematologist Perspective
por: Moiz, Bushra, et al.
Publicado: (2020)

Cancer associated thrombosis: Which lessons for the hematologist?
por: Noble, Simon
Publicado: (2018)

1077. Infectious complications after second allogeneic hematopoietic cell transplant (allo-HCT) in adult patients with hematological malignancies
por: Maurer, Stephen, et al.
Publicado: (2020)

El debate sobre la guerra chichimeca, 1531-1583 : derecho y política en la Nueva España /
por: Carrillo Cázares, Alberto
Publicado: (2000)

P1718: A PROSPECTIVE MULTICENTER SURVEY ABOUT THE USE OF NEW TECHOLOGIES AND DIGITAL HEALTH TOOLS IN PATIENTS (PTS) WITH HEMATOLOGICAL MALIGNANCIES
por: Lopez-Garcia, A., et al.
Publicado: (2022)

P243: Evaluation of the management of infectious risk in a neonatal unit in Dakar
por: Ndir, A, et al.
Publicado: (2013)

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics
por: van der Lee, Maaike, et al.
Publicado: (2019)

Universal iron fortification of foods: the view of a hematologist
por: Martins, José Murilo
Publicado: (2012)

Cancer-associated thrombosis (CAT) - New challenges for the hematologist
por: Brækkan, Sigrid
Publicado: (2018)

Introduction to a review series on COVID-19 and the hematologist
por: Ortel, Thomas L., et al.
Publicado: (2022)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
por: Losa-Rodríguez, Rita, et al.
Publicado: (2020)

Chemotherapy-related infectious complications in patients with Hematologic malignancies
por: Rusu, Raluca-Ana, et al.
Publicado: (2018)

Transfusion Practices in the Management of Sickle Cell Disease: A Survey of Florida Hematologists/Oncologists
por: Dunbar, Levette N., et al.
Publicado: (2012)

La administración del Colegio de San Pedro y San Pablo (1583-1584)
por: Mijares, Ivonne
Publicado: (1986)

Educational needs of hematologists and laboratory professionals regarding factor activity assays
por: Adcock, Dorothy M, et al.
Publicado: (2018)

Bortezomib Prescription Pattern for the Treatment of Multiple Myeloma by Hematologists in Nigeria
por: Korubo, Kaladada I., et al.
Publicado: (2017)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
por: Carreau, Nicole A., et al.
Publicado: (2019)

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
por: Crisà, Elena, et al.
Publicado: (2021)

P1614: MOLECULAR EPIDEMIOLOGY OF INFLUENZA VIRUS IN PATIENTS WITH HEMATOLOGIC DISORDERS
por: Ünal, S., et al.
Publicado: (2022)

P121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis
por: Cenk, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_obf8bqa5un6p84p52tpl7tpcol